The Validation of a Caregiver Assessment of Dementia: The Dementia Severity Scale

Objective:The objective of this study was to refine and validate the Dementia Severity Scale (DSS), a newly developed assessment of dementia severity from a caregiver's perspective. The Dementia Severity Scale is designed to measure deficits in activities of daily living (ADL), behavioral disturbances, and the caregiver's perception of the patient's current cognitive abilities. Methods:Community dwelling caregiver/patient dyads were recruited from 12 clinical sites. Patients had a primary dementia diagnosis for at least one year. In this cross-sectional study, caregivers were administered the Dementia Severity Scale, the Quality of Life-Alzheimer's Disease (QOL-AD), the Progressive Deterioration Scale (PDS), and the Neuropsychiatric Inventory (NPI). Patients were administered the Mini-Mental State Examination (MMSE) and the QOL-AD. To evaluate test-retest reliability, 25% of caregivers were randomized to a second visit. Results:One hundred eighty-three caregiver/patient dyads were recruited. Mean caregiver age was 67.5; mean patient age was 78.8; 93% of patients had probable Alzheimer disease. Eighty-eight (48.1%) patients were male. Exploratory factor analysis established 6 subscales (Activities of Daily Living [ADL], Instrumental ADL [IADL], Communication, Agitation, Memory, and Disorganized Thinking). Cronbach's alphas ranged from 0.82 to 0.90 for the 6 subscales. Test-retest reliability was good with intraclass correlation coefficients ranging from 0.79 to 0.89. DSS subscales were moderately-to-highly correlated with the QOL-AD, NPI, MMSE, and PDS. Subscales significantly discriminated among severity levels of dementia, identified by both physician ratings and MMSE scores. Conclusion:The Dementia Severity Scale demonstrated excellent psychometric properties and appears to be useful both in clinical practice and research endeavors. Further research is needed to establish the longitudinal sensitivity of the Dementia Severity Scale to the progression of dementia.

[1]  D. Bennett,et al.  Alzheimer disease in the US population: prevalence estimates using the 2000 census. , 2003, Archives of neurology.

[2]  T. Erkinjuntti,et al.  RIVASTIGMINE IN PATIENTS WITH ALZHEIMER'S DISEASE AND CONCURRENT HYPERTENSION , 2002, International journal of clinical practice.

[3]  Laura E. Gibbons,et al.  Assessing Quality of Life in Older Adults With Cognitive Impairment , 2002, Psychosomatic medicine.

[4]  Steven G Potkin,et al.  The ABC of Alzheimer's Disease: ADL and Improving Day-to-Day Functioning of Patients , 2002, International Psychogeriatrics.

[5]  C. Wolfson,et al.  Factors associated with long-term institutionalization of older people with dementia: data from the Canadian Study of Health and Aging. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.

[6]  D. Wilkinson,et al.  Galantamine: a randomized, double‐blind, dose comparison in patients with Alzheimer's disease , 2001, International journal of geriatric psychiatry.

[7]  C. Bell,et al.  The Association Between Caregiver Burden and Caregiver Health-Related Quality of Life in Alzheimer Disease , 2001, Alzheimer disease and associated disorders.

[8]  C. Cipolli,et al.  The validity of informant report for grading the severity of Alzheimer’s Dementia , 2001, Aging.

[9]  J. Gallo,et al.  Performance characteristics of a two-stage dementia screen in a population sample. , 2000, Journal of clinical epidemiology.

[10]  L. Schneider,et al.  Can caregivers independently rate cognitive and behavioral symptoms in Alzheimer's disease patients?: A longitudinal analysis. , 1999, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[11]  L. Waite,et al.  Informant-based staging of dementia using the clinical dementia rating. , 1999, Alzheimer disease and associated disorders.

[12]  C. Cipolli,et al.  The Validity of Informant Reports in Assessing the Severity of Dementia: Evidence from the CAMDEX Interview , 1997, Dementia and Geriatric Cognitive Disorders.

[13]  J. Cummings,et al.  The Neuropsychiatric Inventory , 1997, Neurology.

[14]  Y. Conwell,et al.  Screening for depression in elderly primary care patients. A comparison of the Center for Epidemiologic Studies-Depression Scale and the Geriatric Depression Scale. , 1997, Archives of internal medicine.

[15]  C. Clark,et al.  Performance of the Dementia Severity Rating Scale: A Caregiver Questionnaire for Rating Severity in Alzheimer Disease , 1996, Alzheimer disease and associated disorders.

[16]  J Foote,et al.  Initial reliability and validity of a new retrospective measure of child abuse and neglect. , 1994, The American journal of psychiatry.

[17]  P. Gorelick,et al.  Influence of feelings of burden on the caregiver's perception of the patient's functional status. , 1993, Dementia.

[18]  P. Truax,et al.  Assessment of behavioral problems in dementia: the revised memory and behavior problems checklist. , 1992, Psychology and aging.

[19]  J. Passchier,et al.  Value of the Mini-Mental State Examination and Informants' Data for the Detection of Dementia in Geriatric Outpatients , 1992, Psychological reports.

[20]  T. Tombaugh,et al.  The Mini‐Mental State Examination: A Comprehensive Review , 1992, Journal of the American Geriatrics Society.

[21]  A. la Rue,et al.  Retrospective accounts of dementia symptoms: are they reliable? , 1992, The Gerontologist.

[22]  A. Mackinnon,et al.  Performance of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) as a screening test for dementia , 1991, Psychological Medicine.

[23]  J. Price,et al.  Very mild Alzheimer's disease , 1991, Neurology.

[24]  Ron D. Hays,et al.  Beyond internal consistency reliability: Rationale and user’s guide for Multitrait Analysis Program on the microcomputer , 1990 .

[25]  R DeJong,et al.  Measurement of quality-of-life changes in patients with Alzheimer's disease. , 1989, Clinical therapeutics.

[26]  Linda Teri,et al.  6/Use of the Center for Epidemiological Studies-Depression Scale with Older Adults , 1986 .

[27]  K. Davis,et al.  A new rating scale for Alzheimer's disease. , 1984, The American journal of psychiatry.

[28]  B. Reisberg,et al.  The Global Deterioration Scale for assessment of primary degenerative dementia. , 1982, The American journal of psychiatry.

[29]  L. Radloff.  The CES-D Scale , 1977 .

[30]  S. Folstein,et al.  “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician , 1975 .

[31]  L. Cronbach,et al.  Time-limit tests: Estimating their reliability and degree of speeding , 1951, Psychometrika.

[32]  I. Barofsky,et al.  Recommendations on health-related quality of life research to support labeling and promotional claims in the United States , 2004, Quality of Life Research.

[33]  L. Gibbons,et al.  Quality of life in Alzheimer's disease: Patient and caregiver reports. , 1999 .

[34]  M. Sano,et al.  An Inventory to Assess Activities of Daily Living for Clinical Trials in Alzheimer's Disease , 1997, Alzheimer disease and associated disorders.

[35]  P. Tariot,et al.  Measures of Psychiatric Symptoms in Alzheimer Patients: A Review , 1996, Alzheimer disease and associated disorders.

[36]  Dorothy M. Bernstein,et al.  Images in Psychiatry , 1994 .

[37]  G. Groth-Marnat.  Handbook of Psychological Assessment , 2016 .